The Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Scientific Context, Study Design, and Progress Toward Biomarker Qualification.

MLA

McPartland, James C., et al. “The Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Scientific Context, Study Design, and Progress Toward Biomarker Qualification.” Frontiers in Integrative Neuroscience, vol. 14, Apr. 2020, p. 16. EBSCOhost, https://doi.org/10.3389/fnint.2020.00016.

APA

McPartland, J. C., Bernier, R. A., Jeste, S. S., Dawson, G., Nelson, C. A., Chawarska, K., Earl, R., Faja, S., Johnson, S. P., Sikich, L., Brandt, C. A., Dziura, J. D., Rozenblit, L., Hellemann, G., Levin, A. R., Murias, M., Naples, A. J., Platt, M. L., Sabatos-DeVito, M., … Webb, S. J. (2020). The Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Scientific Context, Study Design, and Progress Toward Biomarker Qualification. Frontiers in Integrative Neuroscience, 14, 16. https://doi.org/10.3389/fnint.2020.00016

Chicago

McPartland, James C, Raphael A Bernier, Shafali S Jeste, Geraldine Dawson, Charles A Nelson, Katarzyna Chawarska, Rachel Earl, et al. 2020. “The Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Scientific Context, Study Design, and Progress Toward Biomarker Qualification.” Frontiers in Integrative Neuroscience 14 (April): 16. doi:10.3389/fnint.2020.00016.